<DOC>
	<DOCNO>NCT01505803</DOCNO>
	<brief_summary>Diabetes Mellitus ( DM ) major risk factor cardiovascular disease , 50 % diabetes-associated death attribute cardiovascular complication . The characterising feature DM include : presence chronic hyperglycaemia , consequent upon decreased secretion action insulin ; dyslipidaemia ; enhance level oxidative stress inflammation . Zinc omega 3 polyunsaturated fatty acid show influence outcome via several mechanism . This pilot study examine effect nutritional supplement contain zinc omega 3 outcome population type 2 DM .</brief_summary>
	<brief_title>The Effect Nutritional Supplement Individuals With Type 2 Diabetes Mellitus : Pilot Study</brief_title>
	<detailed_description>The prevalence type 2 DM related-complications continue increase . Diet significant factor aetiology type 2 DM . Intakes zinc omega 3 fatty acid may modulate glycaemic control , lipid metabolism , inflammatory process disease . Zinc involve many biological process include enzyme action , stabilisation cell membrane , regulation gene expression , cell signalling . Zinc supplementation demonstrate improve glycaemic control animal human . The normalising effect zinc glucose homeostasis may relate involvement insulin metabolism . Zinc function synthesis , storage , secretion , action insulin . Omega-3 also enhance glycaemic control dietary supplementation omega-3 polyunsaturated fatty acid show improve insulin sensitivity subject DM . Both zinc omega-3 function mediate lipid metabolism . Zinc supplementation find associate beneficial increase HDL cholesterol concentration individual type 2 DM . The mechanism may involve insulin , propose independent predictor plasma HDL . Omega-3 directly activate transcription factor regulate lipid metabolism know decrease serum triglyceride level DM . Zinc appear beneficially impact oxidative stress-related parameter DM via range mechanism , include regulation copper , zinc superoxide dismutase , metallothionein , NF-ÎºB nitric oxide signal . The purpose pilot study explore effect zinc omega 3 supplementation hyperglycaemia , dyslipidaemia , chronic inflammation , oxidative stress population type 2 DM . This study recruit 48 postmenopausal woman type 2 DM . Participants randomly allocate one 4 group period 12 week : placebo , zinc , omega 3 , zinc + omega 3 supplementation . Usual dietary intake assess trial period use 2-day estimate food record , check research dietitian . Blood sample collect participant start intervention ( week 0 ) 4 weekly interval ( week 4 , 8 , 12 ) qualify phlebotomist . Blood sample analyse plasma zinc , plasma lipid fatty acid , marker inflammation oxidative stress , indicator glycaemic control . An aliquot blood also use measurement zinc transporter mRNA level utilise real-time quantitative PCR technique .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>Female , postmenopausal Type 2 diabetes ( control diet lifestyle ; oral hypoglycaemic medication ( i.e . metformin ) 7 year ) Normal Glomerular Filtration Rate ( GFR ) normal microalbumin/creatine ratio No nutritional supplement 6 week prior trial &amp; continue trial period Nonsmoking Diagnosed current major illness ( renal disease , significant cardiovascular disease , gastrointestinal disorder , cancer , significant disorder likely interfere zinc metabolism ) Taking medication likely interfere zinc metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Dietary supplement</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Zinc</keyword>
	<keyword>Omega 3</keyword>
</DOC>